Cloning Technology: Control the Bonanza for Research Eggs
By Marcy Darnovsky, Susan Berke Fogel, Judy Norsigian,
Nature
| 12. 01. 2011
[Letter to the editor]
The demand for women’s eggs for research could soar alarmingly following news of a cloning technique that uses human oocytes to reprogram somatic cells to a state of pluripotency (S. Noggle et al. Nature 478, 70–75; 2011).
The mean number of eggs given by each woman during the study was 16.9, with one donating 26 eggs. This is more than many fertility doctors would consider optimal and increases the risk of ovarian hyperstimulation syndrome. The researchers do not say that they halted hormone treatment in cases of over-response, although they did stop it in under-responsive women.
Noggle et al. rightly anticipated concerns that payment for eggs could encourage financially disadvantaged women to take risks they might otherwise avoid. But US$8,000, the amount paid by Noggle and colleagues, would be a temptation even to the well-off in these difficult economic times.
Some argue that women should evaluate for themselves the risks and benefits of providing eggs for research. But informed consent depends on provision of accurate information. Even after years of egg harvesting for fertility treatment, the risks to women —...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...